Advertisement
Lantheus Holdings, Inc.

Lantheus Holdings, Inc. (LNTH) Stock Overview

Explore Lantheus Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

LNTHNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$109.80
$0.79(0.72%)
U.S. Market opens in 54h 48m
Advertisement

Lantheus Holdings, Inc. (LNTH)

Meyka AI Score

Z

Key Financials

Market Cap7.1B
P/E Ratio26.07
EPS (TTM)$5.97
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$98.28
3 Months$46.55
1 Year Target$78.49

LNTH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lantheus Holdings, Inc. (LNTH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 71.02, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $78.49.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 26.07 and a market capitalization of 7.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.60%
5-Day Change
4.97%
1-Month Change
9.59%
3-Month Change
43.61%
6-Month Change
64.38%
Year-to-Date (YTD) Change
64.78%
1-Year Change
35.82%
3-Year Change
26.80%
5-Year Change
303.61%
All-Time (Max) Change
1519.79%

Contact Information

978 671 8001
331 Treble Cove Road, Bedford, MA, 01862

Company Facts

8,080 Employees
IPO DateJun 25, 2015
CountryUS
Actively Trading

Frequently Asked Questions